{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-044431","form_type":"8-K","ticker":"BMRA","cik":"0000073290","company_name":"BIOMERICA INC","filed_at":"2023-12-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.864554+00:00","generated_at":"2026-06-07T15:17:51.956062+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Biomerica reports voting results from 2023 annual meeting","bullets":["Stockholders elected six director nominees: Zackary Irani (5,973,554 for), Allen Barbieri, Jane Emerson, Catherine Coste, David Moatazedi, Jack Kenny.","Advisory vote on named executive officer compensation ratified: 5,964,147 for, 94,156 against, 6,806 abstentions.","Ratified Haskell & White LLP as auditor for FY ending May 31, 2024: 10,546,099 for, 21,702 against, 6,381 abstentions.","Approved 2023 Stock Incentive Plan: 5,515,057 for, 87,185 against, 462,867 abstentions, 4,509,073 broker non-votes.","Approved adjournment of annual meeting if necessary: 5,906,540 for, 152,436 against, 6,133 abstentions."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-044431","json":"https://secwatch.observer/filing/0001493152-23-044431.json","markdown":"https://secwatch.observer/filing/0001493152-23-044431.md","text":"https://secwatch.observer/filing/0001493152-23-044431.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/73290/000149315223044431/0001493152-23-044431-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/73290/000149315223044431/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T15:17:51.956062+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"395bc6d2cbbd4c6e9539d1695692286f9add760d","claim":"BIOMERICA INC shareholders approved Ratification and approval of the 2023 Stock Incentive Plan at the 2023-12-07 meeting.","evidence_excerpt":"Proposal No. 4 : The shareholders voted to ratify and approve the 2023 Stock Incentive Plan.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/73290/000149315223044431/0001493152-23-044431-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-07"}],"fact_type":"shareholder_vote"},{"claim_id":"653a70d1804721ad73f1ef8202752b624e96951d","claim":"BIOMERICA INC shareholders approved Ratification of the advisory vote on the named executive officers’ compensation at the 2023-12-07 meeting.","evidence_excerpt":"Proposal No. 2 : The Company’s stockholders ratified the advisory vote on the named executive officers’ compensation.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/73290/000149315223044431/0001493152-23-044431-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-07"}],"fact_type":"shareholder_vote"},{"claim_id":"828982ff31f4bbfddffa3c226a8b5896caf4da31","claim":"BIOMERICA INC shareholders approved Ratification and approval of an adjournment of the Annual Meeting, if necessary or appropriate, including to establish a quorum at the 2023-12-07 meeting.","evidence_excerpt":"Proposal No. 5 : The shareholders ratified and approved an adjournment of the Annual Meeting, if necessary or appropriate, including to establish a quorum.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/73290/000149315223044431/0001493152-23-044431-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-07"}],"fact_type":"shareholder_vote"},{"claim_id":"8a7c9a1661b4b0eeb5114bfa7984852946a81750","claim":"BIOMERICA INC shareholders approved Election of six nominees to the Board of Directors at the 2023-12-07 meeting.","evidence_excerpt":"Proposal No. 1 : The Company’s stockholders elected each of the six nominees named below to serve on the Company’s Board of Directors until the next annual meeting of stockholders of the Company and until his or her successor has been elected and qualified or until his or her earlier resignation, death or removal.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/73290/000149315223044431/0001493152-23-044431-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-07"}],"fact_type":"shareholder_vote"},{"claim_id":"970fa73b3ad3c5fc7f3697b8466d9374380c6628","claim":"BIOMERICA INC shareholders approved Ratification of the appointment of Haskell & White LLP as the Company’s independent public accounting firm for the fiscal year ending May 31, 2024 at the 2023-12-07 meeting.","evidence_excerpt":"Proposal No. 3 : The Company’s stockholders ratified the appointment of Haskell & White LLP as the Company’s independent public accounting firm for the fiscal year ending May 31, 2024.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/73290/000149315223044431/0001493152-23-044431-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-07"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}